O'Neil BH - Search Results

1

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).

Nixon AB, Sibley AB, Liu Y, Hatch AJ, Jiang C, Mulkey F, Starr MD, Brady JC, Niedzwiecki D, Venook AP, Baez-Diaz L, Lenz HJ, O'Neil BH, Innocenti F, Meyerhardt JA, O'Reilly EM, Owzar K, Hurwitz HI. Nixon AB, et al. Among authors: o neil bh. Clin Cancer Res. 2022 Jul 1;28(13):2779-2788. doi: 10.1158/1078-0432.CCR-21-2389. Clin Cancer Res. 2022. PMID: 34965954 Free PMC article.

2

Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.

O'Neil BH, Goldberg RM. O'Neil BH, et al. Expert Opin Investig Drugs. 2003 Dec;12(12):1939-49. Expert Opin Investig Drugs. 2003. PMID: 14640938 Review.

3

The proteasome as a target for cancer therapy.

Voorhees PM, Dees EC, O'Neil B, Orlowski RZ. Voorhees PM, et al. Clin Cancer Res. 2003 Dec 15;9(17):6316-25. Clin Cancer Res. 2003. PMID: 14695130 Review.

4

Chemotherapy for advanced colorectal cancer: let's not forget how we got here (until we really can).

O'Neil BH, Goldberg RM. O'Neil BH, et al. Semin Oncol. 2005 Feb;32(1):35-42. doi: 10.1053/j.seminoncol.2004.09.030. Semin Oncol. 2005. PMID: 15726504 Review.

5

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas.

Burris HA 3rd, Hurwitz HI, Dees EC, Dowlati A, Blackwell KL, O'Neil B, Marcom PK, Ellis MJ, Overmoyer B, Jones SF, Harris JL, Smith DA, Koch KM, Stead A, Mangum S, Spector NL. Burris HA 3rd, et al. J Clin Oncol. 2005 Aug 10;23(23):5305-13. doi: 10.1200/JCO.2005.16.584. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955900 Clinical Trial.

6

A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.

Ryan DP, O'Neil BH, Supko JG, Rocha Lima CM, Dees EC, Appleman LJ, Clark J, Fidias P, Orlowski RZ, Kashala O, Eder JP, Cusack JC Jr. Ryan DP, et al. Cancer. 2006 Dec 1;107(11):2688-97. doi: 10.1002/cncr.22280. Cancer. 2006. PMID: 17075878 Free article. Clinical Trial.

7

Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.

O'Neil BH, Venook AP. O'Neil BH, et al. Oncologist. 2007 Dec;12(12):1425-32. doi: 10.1634/theoncologist.12-12-1425. Oncologist. 2007. PMID: 18165619 Free article. Review.

8

Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.

Kozuch PS, Rocha-Lima CM, Dragovich T, Hochster H, O'Neil BH, Atiq OT, Pipas JM, Ryan DP, Lenz HJ. Kozuch PS, et al. J Clin Oncol. 2008 May 10;26(14):2320-6. doi: 10.1200/JCO.2007.14.0152. J Clin Oncol. 2008. PMID: 18467723 Clinical Trial.

9

Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.

O'Neil BH, Goldberg RM. O'Neil BH, et al. Oncologist. 2008 Oct;13(10):1074-83. doi: 10.1634/theoncologist.2008-0083. Epub 2008 Oct 15. Oncologist. 2008. PMID: 18922828 Free article. Review.

10

A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher.

Shah U, O'Neil B, Allen J, Goldberg RM, Bernard S, Moore D, Venook AP, Morse MM. Shah U, et al. Gastrointest Cancer Res. 2009 Mar;3(2):45-8. Gastrointest Cancer Res. 2009. PMID: 19461906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page